Castle Biosciences, Inc. ( CSTL) - Key Metrics
CSTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.41 | -$0.07 | $0.50 | $0.22 |
| 2026Q1 | $2.80 | -$0.49 | -$0.74 | -$1.16 |
| 2025Q4 | $2.97 | -$0.08 | $0.92 | $0.67 |
| 2025Q3 | $3.32 | -$0.02 | $0.90 | $0.31 |
| 2025Q2 | $2.98 | $0.16 | $0.72 | $0.40 |
CSTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -85.18 |
| 2026Q1 | 0% | -12.53 |
| 2025Q4 | 0% | -122.33 |
| 2025Q3 | 0% | -284.63 |
| 2025Q2 | 0% | 31.91 |
CSTL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.90% | 0% |
| 2026Q1 | -4.71% | 0% |
| 2025Q4 | 1.73% | 0% |
| 2025Q3 | 1.37% | 0% |
| 2025Q2 | 1.96% | 0% |
CSTL
Price: $32.91
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 126500
Market Capitalization: 1.0 billion